Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-30 9:28 pm Sale |
2025-07-25 | 13D | Ikena Oncology, Inc. IKNA |
ORBIMED ADVISORS LLC | 773,754 6.920% |
-7,235,159 (-90.34%) |
Filing History |
| 2025-07-24 5:44 pm Sale |
2025-07-22 | 13D | Passage Bio, Inc. PASG |
ORBIMED ADVISORS LLC | 132,473 4.250% |
-111,405 (-45.68%) |
Filing History |
| 2025-07-21 5:28 pm Sale |
2025-07-17 | 13D | Passage Bio, Inc. PASG |
ORBIMED ADVISORS LLC | 243,878 7.820% |
-5,679,656 (-95.88%) |
Filing History |
| 2025-07-09 8:06 pm Sale |
2025-07-07 | 13D | Passage Bio, Inc. PASG |
ORBIMED ADVISORS LLC | 5,923,534 9.500% |
-726,466 (-10.92%) |
Filing History |
| 2025-06-18 8:23 pm Purchase |
2025-06-14 | 13D | Ikena Oncology, Inc. IKNA |
ORBIMED ADVISORS LLC | 8,008,913 16.710% |
5,819,802 (+265.85%) |
Filing History |
| 2025-06-17 5:30 pm Unchanged |
2025-06-16 | 13D | Enliven Therapeutics, Inc. ELVN |
ORBIMED ADVISORS LLC | 7,918,163 13.400% |
0 (Unchanged) |
Filing History |
| 2025-05-15 8:15 pm Unchanged |
2025-03-31 | 13G | NeuroPace, Inc. NPCE |
ORBIMED ADVISORS LLC | 3,406,335 10.500% |
0 (Unchanged) |
Filing History |
| 2025-05-15 8:13 pm Unchanged |
2025-03-31 | 13G | InspireMD, Inc. NSPR |
ORBIMED ADVISORS LLC | 2,133,405 7.200% |
0 (Unchanged) |
Filing History |
| 2025-05-15 8:09 pm Purchase |
2025-03-31 | 13G | C4 Therapeutics, Inc. CCCC |
ORBIMED ADVISORS LLC | 4,655,600 6.600% |
4,655,600 (New Position) |
Filing History |
| 2025-05-15 6:46 pm Purchase |
2025-03-31 | 13G | Whitehawk Therapeutics Inc WHWK |
ORBIMED ADVISORS LLC | 4,166,000 8.900% |
4,166,000 (New Position) |
Filing History |
| 2025-05-15 6:41 pm Sale |
2025-03-31 | 13G | Verastem, Inc. VSTM |
ORBIMED ADVISORS LLC | 2,862,448 5.600% |
-1,286,414 (-31.01%) |
Filing History |
| 2025-05-14 8:49 pm Unchanged |
2025-05-12 | 13D | Corvus Pharmaceuticals, Inc. CRVS |
ORBIMED ADVISORS LLC | 9,785,423 12.200% |
0 (Unchanged) |
Filing History |
| 2025-05-12 7:13 pm Purchase |
2025-05-09 | 13D | Edgewise Therapeutics, Inc. EWTX |
ORBIMED ADVISORS LLC | 15,252,867 14.500% |
496,771 (+3.37%) |
Filing History |
| 2025-05-01 9:20 pm Purchase |
2025-04-29 | 13D | Corvus Pharmaceuticals, Inc. CRVS |
ORBIMED ADVISORS LLC | 9,785,423 13.800% |
2,841,769 (+40.93%) |
Filing History |
| 2025-04-25 7:48 pm Sale |
2025-04-22 | 13D | Passage Bio, Inc. PASG |
ORBIMED ADVISORS LLC | 6,650,000 10.700% |
-754,869 (-10.19%) |
Filing History |
| 2025-04-14 7:09 pm Sale |
2025-04-10 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 0 0.000% |
-73,114,592 (Position Closed) |
Filing History |
| 2025-04-11 7:21 pm Sale |
2024-04-09 | 13D | Compass Therapeutics, Inc. CMPX |
ORBIMED ADVISORS LLC | 15,219,994 11.000% |
-3,571,428 (-19.01%) |
Filing History |
| 2025-03-12 7:57 pm Sale |
2025-03-10 | 13D | Disc Medicine, Inc. IRON |
ORBIMED ADVISORS LLC | 1,556,369 4.500% |
-229,202 (-12.84%) |
Filing History |
| 2025-02-14 4:35 pm Purchase |
2024-12-31 | 13G | ADC Therapeutics S.A. ADCT |
ORBIMED ADVISORS LLC | 3,437,813 3.600% |
3,437,813 (New Position) |
Filing History |
| 2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
ORBIMED ADVISORS LLC | 13,135,260 9.900% |
13,135,260 (New Position) |
Filing History |